Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	PIKFYVE CDC42BPG PPM1D PRKAA1 MAP3K14 CAMK1G PRKDC EIF2AK3 MAP3K1	7.91e-06	446	61	9	GO:0004674
GeneOntologyMolecularFunction	protein kinase activity	PIKFYVE CDC42BPG PPM1D PRKAA1 MAP3K14 CAMK1G PRKDC EIF2AK3 MUSK MAP3K1	1.26e-05	600	61	10	GO:0004672
GeneOntologyMolecularFunction	protein serine kinase activity	PIKFYVE CDC42BPG PRKAA1 MAP3K14 CAMK1G PRKDC EIF2AK3 MAP3K1	1.40e-05	363	61	8	GO:0106310
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	PIKFYVE CDC42BPG PPM1D PRKAA1 MAP3K14 CAMK1G PRKDC EIF2AK3 MUSK MAP3K1	5.24e-05	709	61	10	GO:0016773
GeneOntologyMolecularFunction	kinase activity	PIKFYVE CDC42BPG PPM1D PRKAA1 MAP3K14 CAMK1G PRKDC EIF2AK3 MUSK MAP3K1	9.76e-05	764	61	10	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	PIKFYVE CDC42BPG PPM1D PRKAA1 MAP3K14 THG1L CAMK1G PRKDC EIF2AK3 MUSK MAP3K1	1.12e-04	938	61	11	GO:0016772
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEI POTEJ	4.96e-04	11	61	2	GO:0098973
MousePheno	increased granulocyte number	SELE TET2 RAB19 YOD1 DLGAP2 FCGR2A MAP3K14 PRKDC SIRT7 CHORDC1	1.00e-05	597	43	10	MP:0000322
MousePheno	abnormal myeloid leukocyte morphology	SELE TET2 RAB19 YOD1 DLGAP2 NLRP12 THRB FCGR2A MAP3K14 LAMA3 DIP2C PRKDC SIRT7 CHORDC1	1.86e-05	1292	43	14	MP:0008250
MousePheno	abnormal granulocyte number	SELE TET2 RAB19 YOD1 DLGAP2 NLRP12 FCGR2A MAP3K14 PRKDC SIRT7 CHORDC1	2.27e-05	805	43	11	MP:0020201
MousePheno	abnormal granulocyte morphology	SELE TET2 RAB19 YOD1 DLGAP2 NLRP12 FCGR2A MAP3K14 PRKDC SIRT7 CHORDC1	3.18e-05	835	43	11	MP:0002441
MousePheno	abnormal phagocyte morphology	SELE TET2 YOD1 DLGAP2 NLRP12 THRB FCGR2A LAMA3 DIP2C PRKDC SIRT7 CHORDC1	4.45e-05	1033	43	12	MP:0008251
MousePheno	thymus cyst	MAP3K14 PRKDC	5.52e-05	4	43	2	MP:0014130
MousePheno	decreased NK T cell number	MAP3K14 NCF2 PRKDC NUDCD3	7.64e-05	74	43	4	MP:0008040
MousePheno	abnormal immunoglobulin light chain V-J recombination	PRKDC NUDCD3	9.19e-05	5	43	2	MP:0008761
MousePheno	liver inflammation	TET2 FCGR2A MAP3K14 PRKDC SIRT7	1.11e-04	156	43	5	MP:0001860
MousePheno	increased neutrophil cell number	SELE TET2 YOD1 DLGAP2 FCGR2A PRKDC CHORDC1	1.18e-04	368	43	7	MP:0000219
MousePheno	abnormal neutrophil cell number	SELE TET2 YOD1 DLGAP2 NLRP12 FCGR2A PRKDC CHORDC1	1.20e-04	499	43	8	MP:0012440
MousePheno	absent thymus corticomedullary boundary	MAP3K14 PRKDC	1.38e-04	6	43	2	MP:0013741
MousePheno	abnormal neutrophil morphology	SELE TET2 YOD1 DLGAP2 NLRP12 FCGR2A PRKDC CHORDC1	1.41e-04	511	43	8	MP:0005065
MousePheno	myeloid hyperplasia	TET2 PPM1D PRKDC	1.52e-04	34	43	3	MP:0010373
MousePheno	small thymus	PIKFYVE PPM1D MAP3K14 DIP2C PRKDC NUDCD3	2.24e-04	286	43	6	MP:0000706
MousePheno	lung inflammation	FCGR2A MAP3K14 LAMA3 NCF2 PRKDC	2.46e-04	185	43	5	MP:0001861
MousePheno	increased chronic myelocytic leukemia incidence	TET2 CHORDC1	2.56e-04	8	43	2	MP:0005481
MousePheno	increased inflammatory response	SELE TET2 YOD1 NLRP12 FCGR2A MAP3K14 LAMA3 NCF2 PRKDC SIRT7 MAP3K1	3.12e-04	1077	43	11	MP:0001846
MousePheno	abnormal NK T cell morphology	MAP3K14 NCF2 PRKDC NUDCD3	3.18e-04	107	43	4	MP:0008036
MousePheno	abnormal NK T cell number	MAP3K14 NCF2 PRKDC NUDCD3	3.18e-04	107	43	4	MP:0008038
MousePheno	abnormal red blood cell distribution width	PRKAA1 CHD1 NUDCD3 CHORDC1 PTGIS MAP3K1	4.03e-04	319	43	6	MP:0010066
MousePheno	abnormal inflammatory response	SELE TET2 YOD1 NLRP12 FCGR2A PPM1D MAP3K14 LAMA3 NCF2 PRKDC SIRT7 MAP3K1	4.27e-04	1310	43	12	MP:0001845
MousePheno	abnormal myelopoiesis	TET2 PPM1D PRKDC CHORDC1	4.77e-04	119	43	4	MP:0001601
MousePheno	abnormal circulating thyroxine level	ZMYND11 THRB NCF2	5.09e-04	51	43	3	MP:0005475
MousePheno	abnormal endocrine gland morphology	PIKFYVE TET2 ZMYND11 THRB PPM1D MAP3K14 DIP2C PRKDC NUDCD3 EIF2AK3 PTGIS	5.24e-04	1144	43	11	MP:0013560
MousePheno	decreased leukocyte cell number	SELE TET2 RAB19 YOD1 DLGAP2 NLRP12 PPM1D MAP3K14 NCF2 PRKDC NUDCD3 CHORDC1	5.33e-04	1342	43	12	MP:0000221
MousePheno	respiratory system inflammation	FCGR2A MAP3K14 LAMA3 NCF2 PRKDC	5.46e-04	220	43	5	MP:0002405
MousePheno	abnormal germinal center B cell number	FCGR2A MAP3K14 NCF2	6.36e-04	55	43	3	MP:0013680
MousePheno	abnormal germinal center B cell morphology	FCGR2A MAP3K14 NCF2	6.36e-04	55	43	3	MP:0008176
MousePheno	decreased lymphocyte cell number	TET2 RAB19 YOD1 DLGAP2 PPM1D MAP3K14 NCF2 PRKDC NUDCD3 CHORDC1	6.87e-04	992	43	10	MP:0005016
MousePheno	abnormal T cell receptor V(D)J recombination	PRKDC NUDCD3	7.06e-04	13	43	2	MP:0008754
MousePheno	abnormal immunoglobulin V(D)J recombination	PRKDC NUDCD3	7.06e-04	13	43	2	MP:0008755
MousePheno	increased circulating thyroxine level	ZMYND11 THRB	9.46e-04	15	43	2	MP:0005477
Domain	ANK	POTEB3 POTED POTEI POTEJ POTEB2 POTEB	1.38e-04	251	59	6	SM00248
Domain	ANK_REPEAT	POTEB3 POTED POTEI POTEJ POTEB2 POTEB	1.44e-04	253	59	6	PS50088
Domain	ANK_REP_REGION	POTEB3 POTED POTEI POTEJ POTEB2 POTEB	1.47e-04	254	59	6	PS50297
Domain	Ankyrin_rpt	POTEB3 POTED POTEI POTEJ POTEB2 POTEB	1.74e-04	262	59	6	IPR002110
Domain	Protein_kinase_ATP_BS	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MUSK MAP3K1	1.84e-04	379	59	7	IPR017441
Domain	Kinase-like_dom	CDC42BPG PRKAA1 MAP3K14 CAMK1G PRKDC EIF2AK3 MUSK MAP3K1	2.88e-04	542	59	8	IPR011009
Domain	PROTEIN_KINASE_ATP	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MUSK MAP3K1	5.85e-04	459	59	7	PS00107
Domain	Prot_kinase_dom	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MUSK MAP3K1	8.50e-04	489	59	7	IPR000719
Domain	CS	NUDCD3 CHORDC1	8.71e-04	14	59	2	PF04969
Domain	PROTEIN_KINASE_DOM	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MUSK MAP3K1	8.91e-04	493	59	7	PS50011
Domain	Ser/Thr_kinase_AS	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MAP3K1	8.98e-04	357	59	6	IPR008271
Domain	S_TKc	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MAP3K1	9.24e-04	359	59	6	SM00220
Domain	PROTEIN_KINASE_ST	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MAP3K1	9.65e-04	362	59	6	PS00108
Domain	CS_dom	NUDCD3 CHORDC1	1.14e-03	16	59	2	IPR007052
Domain	Actin_CS	POTEI POTEJ	1.14e-03	16	59	2	IPR004001
Domain	CS	NUDCD3 CHORDC1	1.14e-03	16	59	2	PS51203
Domain	Ankyrin_rpt-contain_dom	POTEB3 POTEI POTEJ POTEB2 POTEB	1.23e-03	254	59	5	IPR020683
Domain	Pkinase	CDC42BPG PRKAA1 MAP3K14 CAMK1G EIF2AK3 MAP3K1	1.25e-03	381	59	6	PF00069
Domain	ACTINS_2	POTEI POTEJ	1.29e-03	17	59	2	PS00432
Domain	Actin/actin-like_CS	POTEI POTEJ	1.45e-03	18	59	2	IPR020902
Domain	ACTINS_ACT_LIKE	POTEI POTEJ	1.62e-03	19	59	2	PS01132
Domain	Pentatricopeptide_repeat	PRKDC KLC1	2.38e-03	23	59	2	IPR002885
Domain	-	NUDCD3 CHORDC1	2.38e-03	23	59	2	2.60.40.790
Domain	HSP20-like_chaperone	NUDCD3 CHORDC1	3.04e-03	26	59	2	IPR008978
Domain	Actin	POTEI POTEJ	4.30e-03	31	59	2	IPR004000
Domain	Actin	POTEI POTEJ	4.30e-03	31	59	2	PF00022
Domain	ACTIN	POTEI POTEJ	4.30e-03	31	59	2	SM00268
Domain	Helicase_C	CHD1 DDX60L DDX1	4.71e-03	107	59	3	PF00271
Domain	HELICc	CHD1 DDX60L DDX1	4.71e-03	107	59	3	SM00490
Domain	Ank_2	POTEB3 POTEI POTEJ POTEB2	4.74e-03	215	59	4	PF12796
Domain	Helicase_C	CHD1 DDX60L DDX1	4.83e-03	108	59	3	IPR001650
Domain	HELICASE_CTER	CHD1 DDX60L DDX1	4.96e-03	109	59	3	PS51194
Domain	HELICASE_ATP_BIND_1	CHD1 DDX60L DDX1	4.96e-03	109	59	3	PS51192
Domain	DEXDc	CHD1 DDX60L DDX1	4.96e-03	109	59	3	SM00487
Domain	P-loop_NTPase	RAB19 NLRP12 DNAH12 SULT2A1 MYO1B CHD1 DDX60L DDX1	4.98e-03	848	59	8	IPR027417
Domain	Helicase_ATP-bd	CHD1 DDX60L DDX1	5.09e-03	110	59	3	IPR014001
Domain	Ank	POTED POTEI POTEJ POTEB	5.83e-03	228	59	4	PF00023
Domain	-	POTEB3 POTEI POTEJ POTEB2	7.80e-03	248	59	4	1.25.40.20
Domain	-	RAB19 NLRP12 DNAH12 SULT2A1 CHD1 DDX60L DDX1	8.86e-03	746	59	7	3.40.50.300
Pubmed	POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.	POTEB3 POTED POTEJ POTEB2 POTEB	8.51e-13	8	62	5	12475935
Pubmed	Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths.	POTEB3 POTED POTEB	1.88e-07	7	62	3	15276201
Pubmed	Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.	POTED POTEI POTEJ	4.50e-07	9	62	3	16364570
Pubmed	USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.	HNRNPM MYO1B PRKDC	8.81e-07	11	62	3	35449157
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	PIKFYVE PPM1D MYO1B NUDCD3 POTEI POTEJ ZMYM4 DDX1 KNL1	9.71e-07	588	62	9	38580884
Pubmed	Genetic influences on the end-stage effector phase of arthritis.	SELE FCGR2A NCF2	2.97e-06	16	62	3	11489951
Pubmed	An accessory role of TCRgammadelta (+) cells in the exacerbation of inflammatory bowel disease in TCRalpha mutant mice.	MAP3K14 PRKDC	3.13e-06	2	62	2	11298322
Pubmed	Thyroid hormone receptor beta and NCOA4 regulate terminal erythrocyte differentiation.	THRB NCOA4	3.13e-06	2	62	2	28864529
Pubmed	Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.	FCGR2A PRKDC	3.13e-06	2	62	2	15664957
Pubmed	NLRP12 Promotes Mouse Neutrophil Differentiation through Regulation of Non-canonical NF-κB and MAPKERK1/2 Signaling.	NLRP12 MAP3K14	3.13e-06	2	62	2	29483833
Pubmed	Control of insulin granule dynamics by AMPK dependent KLC1 phosphorylation.	PRKAA1 KLC1	3.13e-06	2	62	2	21099273
Pubmed	Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.	MAP3K14 PRKDC	3.13e-06	2	62	2	18292290
Pubmed	E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.	SELE FCGR2A	3.13e-06	2	62	2	21780194
Pubmed	E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model.	SELE PRKDC	9.37e-06	3	62	2	23922938
Pubmed	The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2.	MAP3K14 MAP3K1	9.37e-06	3	62	2	12049732
Pubmed	Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes.	NLRP12 MAP3K14	9.37e-06	3	62	2	17237370
Pubmed	Intestinal gamma delta T cells develop in mice lacking thymus, all lymph nodes, Peyer's patches, and isolated lymphoid follicles.	MAP3K14 PRKDC	9.37e-06	3	62	2	15699117
Pubmed	Glucose starvation induces autophagy via ULK1-mediated activation of PIKfyve in an AMPK-dependent manner.	PIKFYVE PRKAA1	9.37e-06	3	62	2	34107300
Pubmed	The Vertebrate Genome Annotation browser 10 years on.	POTEB3 POTEI POTEJ POTEB2 POTEB	1.11e-05	163	62	5	24316575
Pubmed	Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase.	MAP3K14 MAP3K1	1.87e-05	4	62	2	9819420
Pubmed	FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival.	FCGR2A PRKDC	1.87e-05	4	62	2	22516957
Pubmed	Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.	PPM1D PRKDC	1.87e-05	4	62	2	20668064
Pubmed	Endosomal phosphoinositides and human diseases.	PIKFYVE SBF2	1.87e-05	4	62	2	18429927
Pubmed	FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.	FCGR2A PRKDC	1.87e-05	4	62	2	36759517
Pubmed	Homeostatic regulation of intestinal villous epithelia by B lymphocytes.	MAP3K14 PRKDC	1.87e-05	4	62	2	11884426
Pubmed	Autoimmune thyroiditis in Fcgamma receptor-deficient nonobese diabetic mice.	FCGR2A PRKDC	3.12e-05	5	62	2	19447681
Pubmed	The Ku70 autoantigen interacts with p40phox in B lymphocytes.	NCF2 PRKDC	3.12e-05	5	62	2	9914162
Pubmed	CGK733-induced LC3 II formation is positively associated with the expression of cyclin-dependent kinase inhibitor p21Waf1/Cip1 through modulation of the AMPK and PERK/CHOP signaling pathways.	PRKAA1 EIF2AK3	3.12e-05	5	62	2	26486079
Pubmed	Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma.	TET2 PRKDC	3.12e-05	5	62	2	34848557
Pubmed	Personalized copy number and segmental duplication maps using next-generation sequencing.	POTEB3 POTEB	3.12e-05	5	62	2	19718026
Pubmed	C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis.	FCGR2A PRKDC	3.12e-05	5	62	2	29233917
Pubmed	HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium.	SELE LAMA3	4.67e-05	6	62	2	9597096
Pubmed	Two novel transcripts encoding two Ankyrin repeat containing proteins have preponderant expression during the mouse spermatogenesis.	POTEB2 POTEB	4.67e-05	6	62	2	17171436
Pubmed	PtdIns5P regulation through evolution: roles in membrane trafficking?	PIKFYVE SBF2	4.67e-05	6	62	2	18774718
Pubmed	Quantitative nanoproteomics for protein complexes (QNanoPX) related to estrogen transcriptional action.	HNRNPM MYO1B PRKDC	5.48e-05	41	62	3	19805454
Pubmed	Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.	NLRP12 FCGR2A PRKAA1 MAP3K14 ULBP1	5.88e-05	231	62	5	21048031
Pubmed	DNA-dependent protein kinase regulates lysosomal AMP-dependent protein kinase activation and autophagy.	PRKAA1 PRKDC	6.53e-05	7	62	2	31983282
Pubmed	Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse.	FCGR2A PRKDC	6.53e-05	7	62	2	33117338
Pubmed	Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase.	MAP3K14 MAP3K1	6.53e-05	7	62	2	16286467
Pubmed	Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients.	MAP3K14 MAP3K1	6.53e-05	7	62	2	19262425
Pubmed	Genetic control of NKT cell numbers maps to major diabetes and lupus loci.	SELE FCGR2A	8.69e-05	8	62	2	12960309
Pubmed	MEKK1 binds raf-1 and the ERK2 cascade components.	NCOA4 MAP3K1	8.69e-05	8	62	2	10969079
Pubmed	MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta.	MAP3K14 MAP3K1	8.69e-05	8	62	2	9689078
Pubmed	TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis.	MAP3K14 MAP3K1	8.69e-05	8	62	2	15001576
Pubmed	Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.	THRB PRKDC	8.69e-05	8	62	2	10823961
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	SBF2 PRKAA1 HNRNPM MYO1B CHD1 PRKDC DDX1	9.60e-05	601	62	7	33658012
Pubmed	Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice.	SELE NCF2	1.39e-04	10	62	2	11197687
Pubmed	Ppm1E is an in cellulo AMP-activated protein kinase phosphatase.	PPM1D PRKAA1	1.39e-04	10	62	2	20801214
Pubmed	CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.	HNRNPM MYO1B PRKDC POTEI POTEJ	1.65e-04	288	62	5	31501420
Pubmed	DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.	HNRNPM MYO1B PRKDC	1.98e-04	63	62	3	37052853
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	PRKAA1 MYO1B CHD1 DDX60L SNX33 MAP3K1 KLC1 KNL1	2.07e-04	910	62	8	36736316
Pubmed	Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN).	DNAH12 LAMA3 MYO1B	2.18e-04	65	62	3	32120844
Pubmed	The Nuclear SUMO-Targeted Ubiquitin Quality Control Network Regulates the Dynamics of Cytoplasmic Stress Granules.	HNRNPM PRKDC DDX1	2.18e-04	65	62	3	32521226
Pubmed	TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF.	NCF2 MYBPC1	2.41e-04	13	62	2	16052631
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	LENG8 HNRNPM MYO1B CHD1 PRKDC NUDCD3 KLC1 KNL1	2.46e-04	934	62	8	33916271
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	PPM1D SBF2 HNRNPM THG1L	2.46e-04	170	62	4	23314748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PIKFYVE SBF2 DIP2C ZNF407 TOGARAM1 ARHGAP28	2.47e-04	493	62	6	15368895
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	LENG8 HNRNPM MYO1B POTEI POTEJ DDX1	2.84e-04	506	62	6	30890647
Pubmed	MAP3Ks as central regulators of cell fate during development.	MAP3K14 MAP3K1	3.23e-04	15	62	2	18855897
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEI POTEJ	3.23e-04	15	62	2	16824795
Pubmed	Phosphorylation of thyroid hormone receptor-associated nuclear receptor corepressor holocomplex by the DNA-dependent protein kinase enhances its histone deacetylase activity.	THRB PRKDC	3.23e-04	15	62	2	17242407
Pubmed	Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis.	MAP3K14 MAP3K1	3.69e-04	16	62	2	18434448
Pubmed	Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.	HNRNPM DDX1	3.69e-04	16	62	2	16230076
Pubmed	SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.	PIKFYVE TET2 CDC42BPG HNRNPM MYO1B	4.22e-04	353	62	5	27545878
Pubmed	Genome-scale RNAi screen for host factors required for HIV replication.	POTEB3 SBF2 PRKAA1 MAP3K14 DDX60L	4.67e-04	361	62	5	18976975
Pubmed	A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.	MAP3K14 HNRNPM NUDCD3 CHORDC1 MUSK	4.79e-04	363	62	5	25036637
Pubmed	Deciphering gene expression program of MAP3K1 in mouse eyelid morphogenesis.	MAP3K1 MYBPC1	5.24e-04	19	62	2	23201579
Pubmed	Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation.	CAMK1G KLC1	5.24e-04	19	62	2	15529118
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	HNRNPM PRKDC ZMYM4 DDX1	6.52e-04	220	62	4	35785414
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	HNRNPM MYO1B PRKDC DDX1	6.63e-04	221	62	4	29991511
Pubmed	p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells.	PRKDC POTEJ	7.06e-04	22	62	2	25331947
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	PRKAA1 HNRNPM SNX33 PRKDC CHORDC1 DDX1 MAP3K1	7.46e-04	844	62	7	25963833
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	PRKAA1 HNRNPM MYO1B PRKDC KNL1	7.50e-04	401	62	5	25852190
Pubmed	A forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity.	MAP3K14 PRKDC	7.72e-04	23	62	2	22761313
Pubmed	IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice.	NLRP12 PRKDC	7.72e-04	23	62	2	34473953
Pubmed	CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1.	HNRNPM PRKDC DDX1	7.94e-04	101	62	3	34462429
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	HNRNPM CHD1 PRKDC ZMYM4 DDX1	8.37e-04	411	62	5	35182466
Pubmed	USP10 regulates B cell response to SARS-CoV-2 or HIV-1 nanoparticle vaccines through deubiquitinating AID.	HNRNPM PRKDC	8.41e-04	24	62	2	34983926
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	THRB HNRNPM MYO1B PRKDC NCOA4 DDX1	8.68e-04	626	62	6	33644029
Pubmed	Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.	HNRNPM MYO1B PRKDC DDX1	9.58e-04	244	62	4	28902428
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DLGAP2 ZMYND11 HNRNPM MAP3K1 KLC1	1.02e-03	430	62	5	35044719
Pubmed	Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses.	HNRNPM PRKDC	1.07e-03	27	62	2	19602484
Pubmed	Drp1 regulates transcription of ribosomal protein genes in embryonic hearts.	PRKAA1 SIRT7	1.07e-03	27	62	2	35099001
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	TET2 HNRNPM	1.07e-03	27	62	2	23395962
Pubmed	Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.	HNRNPM PRKDC	1.15e-03	28	62	2	19596686
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	MYO1B CHD1 PRKDC	1.24e-03	118	62	3	27377895
Pubmed	The TIP60 Complex Is a Conserved Coactivator of HIF1A.	HNRNPM MYO1B PRKDC	1.31e-03	120	62	3	27320910
Pubmed	Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function.	TET2 DDX1	1.32e-03	30	62	2	21946350
Pubmed	Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.	HNRNPM PRKDC	1.32e-03	30	62	2	21575865
Pubmed	Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy.	HNRNPM PRKDC	1.32e-03	30	62	2	35152003
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	HNRNPM MYO1B PRKDC DDX1	1.35e-03	268	62	4	33024031
Pubmed	Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10.	SELE FCGR2A	1.41e-03	31	62	2	15921521
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	HNRNPM POTEI POTEJ DDX1	1.41e-03	271	62	4	32433965
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	TET2 HNRNPM MYO1B PRKDC	1.43e-03	272	62	4	31010829
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	PRKAA1 CHD1 CAMK1G PRKDC	1.51e-03	276	62	4	28319085
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	LENG8 HNRNPM CHD1 PRKDC ZMYM4 DDX1 KNL1	1.51e-03	954	62	7	36373674
Pubmed	Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry.	PPM1D PRKDC	1.69e-03	34	62	2	11101529
Pubmed	Expression of the Bcl-2 protein BAD promotes prostate cancer growth.	MAP3K14 MAP3K1	1.69e-03	34	62	2	19593445
Pubmed	HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.	ZNF594 KLC1	1.69e-03	34	62	2	25925205
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	HNRNPM MYO1B PRKDC DDX1	1.72e-03	286	62	4	32041737
Cytoband	1q32.2	YOD1 CAMK1G	6.16e-04	27	62	2	1q32.2
Cytoband	2q21.1	POTEI POTEJ	2.83e-03	58	62	2	2q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr15q11	POTEB3 POTEB2 POTEB	3.21e-03	217	62	3	chr15q11
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTED POTEI POTEJ POTEB2 POTEB	6.71e-11	13	42	5	685
GeneFamily	Ankyrin repeat domain containing	POTED POTEI POTEJ POTEB2 POTEB	2.34e-04	242	42	5	403
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K14 MAP3K1	1.41e-03	24	42	2	654
Coexpression	GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN	TET2 MAP3K14 SIRT7 CHORDC1 ZMYM4 MAP3K1	7.17e-06	200	61	6	M3377
Coexpression	AIZARANI_LIVER_C23_KUPFFER_CELLS_3	TET2 PLBD1 NLRP12 FCGR2A NCF2 DDX60L	1.27e-05	221	61	6	M39124
Coexpression	TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL	TET2 PLBD1 FCGR2A NCF2 NCOA4 MAP3K1	3.90e-05	270	61	6	M41699
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 CHD1 DDX60L PRKDC CLEC2B	3.27e-07	197	62	6	3cd1c816bc7a57278b2ef615b69545356ab8f522
ToppCell	control-Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 PLBD1 NLRP12 FCGR2A NCF2 NCOA4	3.58e-07	200	62	6	b5d197472799cc61d7497faed91ac2564ae4930a
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|356C / Donor, Lineage, Cell class and subclass (all cells)	TET2 CDC42BPG DLGAP2 NLRP12 SULT2A1	3.41e-06	165	62	5	35a6de30438de364ccca948fc932da541a69ef89
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	NLRP12 FCGR2A SBF2 NCF2 MAP3K1	6.61e-06	189	62	5	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 CHD1 PRKDC CLEC2B	6.96e-06	191	62	5	47156e5f1d790707f42f6283104a44b33af613e5
ToppCell	Children_(3_yrs)-Immune-monocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TET2 DLGAP2 NLRP12 FCGR2A MAP3K1	7.32e-06	193	62	5	58e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 DDX60L PRKDC CLEC2B	7.89e-06	196	62	5	fe8d3f45a64323947c36b127355d5940eb56c0ca
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	TET2 FCGR2A SBF2 NCF2 MAP3K1	7.89e-06	196	62	5	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TET2 FCGR2A CHD1 CHORDC1 EIF2AK3	7.89e-06	196	62	5	01cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 DDX60L PRKDC CLEC2B	7.89e-06	196	62	5	526d037bb12d81f1c235c60ddc787fbad0bbad77
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|lung / Disease (COVID-19 only), tissue and cell type	NLRP12 FCGR2A NCF2 DDX60L MAP3K1	8.08e-06	197	62	5	a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 CHD1 DDX60L CLEC2B	8.08e-06	197	62	5	340ce4fef244176fb52e38ffbcbdfda5ac3467dd
ToppCell	COVID-19_Severe-Neu_1\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	TET2 FCGR2A NCF2 DDX60L CLEC2B	8.28e-06	198	62	5	bbe639ea5a636c985e509fb0a133ae3b60afac5a
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TET2 FCGR2A NCF2 CHD1 DDX60L	8.49e-06	199	62	5	5b6feacb0ca92c3fc6b327be978320426dcf6f68
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLBD1 FCGR2A NCF2 DDX60L CHORDC1	8.49e-06	199	62	5	fde8e3ba19d19069a4d3b8db55bfe6220cf634d5
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 CHD1 DDX60L CLEC2B	8.49e-06	199	62	5	9da8b48ec1c1c105fcbab6ae8f08166e7d5e8a35
ToppCell	COVID-19_Severe-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	TET2 FCGR2A NCF2 DDX60L CLEC2B	8.49e-06	199	62	5	e4d8bf016fd95a440e30014a75587e097e90cfad
ToppCell	Biopsy_IPF-Immune-Monocytes\|Biopsy_IPF / Sample group, Lineage and Cell type	TET2 NLRP12 FCGR2A NCF2 CHD1	8.70e-06	200	62	5	80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SBF2 DIP2C ZNF57 KIR2DL4	6.31e-05	154	62	4	ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	YOD1 CDC42BPG DLGAP2 SULT2A1	8.64e-05	167	62	4	7e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic\|GI_small-bowel / Manually curated celltypes from each tissue	PLBD1 NLRP12 FCGR2A NCF2	9.46e-05	171	62	4	098a7fd387357c0d4e1a6169af4d24ef95b30018
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLRP12 FCGR2A NCF2 CLEC2B	9.46e-05	171	62	4	ef9397cec7f5c217d34583f26270af7ed7fbcebf
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	PLBD1 NLRP12 FCGR2A NCF2	1.01e-04	174	62	4	05d54a36772f096047521e16a89cc42ae48d2a1d
ToppCell	3'-Adult-Distal_Rectal-Epithelial-Tuft-related-Microfold_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA3 ARHGAP28 NCF2 MYBPC1	1.03e-04	175	62	4	8a37b2811f39bb9baa537e8755a29d559eb8185a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 THG1L NUDCD3 NCOA4	1.10e-04	178	62	4	be4976bbfd9ebbc568155ede99a07670c43aa372
ToppCell	3'-Adult-Distal_Rectal-Epithelial-Tuft-related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA3 ARHGAP28 NCF2 MYBPC1	1.10e-04	178	62	4	a95bb77a2c2ce7c38989e6f971812f7ee9f5bd4b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 THG1L NUDCD3 NCOA4	1.10e-04	178	62	4	91bf3c7c05d2e67ee590389a1b36c517d0ed7ebf
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKAA1 MYO1B NCF2 PTGIS	1.13e-04	179	62	4	f99500c4a590e5152ded5862690f7fa614d64a80
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKAA1 MYO1B NCF2 PTGIS	1.13e-04	179	62	4	7d61466181ab73088de3ec8a129d7cfa8cac7ecc
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKAA1 MYO1B NCF2 PTGIS	1.13e-04	179	62	4	6c98ce32cb55cf9cee557449e41b23bdb22f5efd
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	PLBD1 NLRP12 FCGR2A NCF2	1.18e-04	181	62	4	921e917f83105896ad8918dc134b871708024021
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLBD1 NLRP12 FCGR2A NCF2	1.20e-04	182	62	4	243c783675df495ea4112dbf710712c44ea6b4f1
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLBD1 NLRP12 FCGR2A NCF2	1.20e-04	182	62	4	18790a394dc32b3cef99cdbf826392c520e38b4a
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP12 FCGR2A NCF2 CHD1	1.23e-04	183	62	4	cff3197e9ff401362501db2317c86adc6d24b595
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP12 FCGR2A NCF2 CHD1	1.23e-04	183	62	4	f803dd2881ceaed6327e21a1a51bc3d3ccf4b5f8
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP12 FCGR2A NCF2 CHD1	1.23e-04	183	62	4	4bd6883daf2dbe8c1b49b776b48d41f9890d1cb4
ToppCell	NS-moderate-d_07-13-Myeloid-Neutrophil\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FCGR2A NCF2 DDX60L CLEC2B	1.25e-04	184	62	4	4c7d05f1a4556b13cedbaaf88d67ac32d09b109b
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 DDX60L CLEC2B	1.28e-04	185	62	4	f30fb9d75cdb757b206312992aaf7485bc900f96
ToppCell	proximal-3-Hematologic-Myeloid_Dendritic_Type_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP3K14 SIRT7 PTGIS KNL1	1.31e-04	186	62	4	c920dffd24f051b54d8b48f801fffc928d99e135
ToppCell	proximal-Hematologic-Myeloid_Dendritic_Type_1-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP3K14 SIRT7 PTGIS KNL1	1.31e-04	186	62	4	d740aca5dc4240851ba7bc5988c0970d785ad0c2
ToppCell	proximal-Hematologic-Myeloid_Dendritic_Type_1\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP3K14 SIRT7 PTGIS KNL1	1.31e-04	186	62	4	4ca7f6c043874a0c536f75af5ca24c7c66725e54
ToppCell	LPS-IL1RA+antiTNF-Myeloid\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLBD1 NLRP12 FCGR2A NCF2	1.34e-04	187	62	4	4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ZNF407 CHD1 CHORDC1 EIF2AK3	1.36e-04	188	62	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	3'_v3-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	PLBD1 NLRP12 FCGR2A NCF2	1.39e-04	189	62	4	74a5e61cd820f2495dde40e766c771a31d8c4e7d
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TET2 PLBD1 NLRP12 NCF2	1.39e-04	189	62	4	55aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LPCAT3 MAP3K14 CHD1 CHORDC1	1.51e-04	193	62	4	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	Macrophages-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	PLBD1 FCGR2A NCF2 CLEC2B	1.51e-04	193	62	4	18534bd60bdd1ce51f948380c78017679931b8b1
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	THRB SBF2 ARHGAP28 MAP3K1	1.54e-04	194	62	4	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	Macrophages-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	PLBD1 FCGR2A NCF2 CLEC2B	1.54e-04	194	62	4	54fda501ce1d041285d04c3c96c15983f454bed4
ToppCell	MNPs\|World / lung cells shred on cell class, cell subclass, sample id	PLBD1 FCGR2A NCF2 CLEC2B	1.57e-04	195	62	4	bd84ceae79115afd13346d8d66da30232a0952a9
ToppCell	mild-Myeloid-Neutrophils_3\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PLBD1 NLRP12 FCGR2A NCF2	1.57e-04	195	62	4	a1cfed0092debcc003eff6a62508556b7664d5e1
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 NLRP12 FCGR2A NCF2	1.57e-04	195	62	4	b0dbaae86f5703ab62f925e0f36500274044884a
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PLBD1 NLRP12 FCGR2A NCF2	1.57e-04	195	62	4	0110b976f98561ecd2e20ff6e7e3960a401bb7c2
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 NLRP12 FCGR2A NCF2	1.57e-04	195	62	4	580ed65b4152483b642a7e7dbdf00d03588c46f6
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	PLBD1 FCGR2A NCF2 NCOA4	1.57e-04	195	62	4	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLBD1 NLRP12 FCGR2A NCF2	1.57e-04	195	62	4	050fc59b328391d6e3ce23051764a842dcbb3144
ToppCell	VE-granulo1-\|VE / Condition, Cell_class and T cell subcluster	DLGAP2 PLBD1 FCGR2A NCF2	1.60e-04	196	62	4	ab3f2ce294c7e503d86254a195be0cf500a2c5e4
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 FCGR2A NCF2 NCOA4	1.60e-04	196	62	4	1d170422a9eb5e477ce837f9da1c7db95ee5da1c
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 DDX60L CLEC2B	1.60e-04	196	62	4	6230b4a26770d30f1ab83345c087f03be1be0f9e
ToppCell	distal-Epithelial-Alveolar_Epithelial_Type_1-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDC42BPG SULT2A1 LAMA3 MYO1B	1.60e-04	196	62	4	b74dbdfc8d9b85d7cae5c6a49b56347b15ce16e1
ToppCell	COVID-19_Severe-Neu_0\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	FCGR2A NCF2 DDX60L CLEC2B	1.60e-04	196	62	4	4831243fcd680cf4821fa0246e758c3e7c13a962
ToppCell	COVID-19-Myeloid-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	TET2 FCGR2A SBF2 NCF2	1.60e-04	196	62	4	4929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell	VE-granulo1\|VE / Condition, Cell_class and T cell subcluster	DLGAP2 PLBD1 FCGR2A NCF2	1.60e-04	196	62	4	6dbd3acb30173d7f0b7bca0a82f435f00ca85835
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TET2 NLRP12 SBF2 MAP3K1	1.60e-04	196	62	4	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 DDX60L CLEC2B	1.60e-04	196	62	4	d9b5eaca4089d5337f1175a663418c9c675cdd87
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLBD1 FCGR2A NCF2 CHORDC1	1.60e-04	196	62	4	5fe6534af65d43eeacd4b031310242b4f706008b
ToppCell	ILEUM-non-inflamed-(3)_Resident_macrophages\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PLBD1 FCGR2A NCF2 NCOA4	1.63e-04	197	62	4	3af24354b6a93c7d105b9fa6549cf215107b9203
ToppCell	COVID-granulo1-\|COVID / Condition, Cell_class and T cell subcluster	TET2 PLBD1 NLRP12 NCF2	1.63e-04	197	62	4	190392117dc6269a21983bd3e554066fd48acd5e
ToppCell	distal-1-Epithelial-Alveolar_Epithelial_Type_1\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDC42BPG SULT2A1 LAMA3 MYO1B	1.63e-04	197	62	4	d44b7dc7c6416ed9466889374c3ae39f43ac8bb6
ToppCell	COVID-granulo1\|COVID / Condition, Cell_class and T cell subcluster	TET2 PLBD1 NLRP12 NCF2	1.63e-04	197	62	4	4cd774d9d5a6bf7729dc6b7bcd3ddfe3f3051ada
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 FCGR2A NCF2 NCOA4	1.63e-04	197	62	4	2afc23f7394d9b40bdf06527c5e6b553e1b02dca
ToppCell	10x_3'_v3-blood_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 NLRP12 NCF2 NCOA4	1.63e-04	197	62	4	2d3547107c88c7443fc6425742694e13368a71f5
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR2A NCF2 DDX60L CLEC2B	1.63e-04	197	62	4	037f5f26fa66818baa35846aa96336155e8a6f45
ToppCell	ILEUM-non-inflamed-(3)_MNP\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PLBD1 FCGR2A NCF2 NCOA4	1.63e-04	197	62	4	64fdc12e7ffade669cc1de081b10e84a27f0d1b5
ToppCell	Control-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	PLBD1 FCGR2A NCF2 NCOA4	1.63e-04	197	62	4	eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TET2 FCGR2A NCF2 CHD1	1.63e-04	197	62	4	f431f11196dc4332933b5d71c7c7408d54c2dedc
ToppCell	COVID-19_Moderate-Classical_Monocyte\|COVID-19_Moderate / disease group, cell group and cell class	PLBD1 NLRP12 FCGR2A NCF2	1.63e-04	197	62	4	98d4107e457e7399a84439acd73bf8f59598971b
ToppCell	critical-Myeloid-Neutrophil\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FCGR2A NCF2 DDX60L CLEC2B	1.63e-04	197	62	4	f1248781e71e3a158d06e9ec93eb90dc6d48bcb2
ToppCell	control-Myeloid-Neutrophils_2\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FCGR2A NCF2 DDX60L CLEC2B	1.63e-04	197	62	4	8819db1550bf14566c6d33d97f7f83419e867ace
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TET2 NLRP12 FCGR2A NCF2	1.63e-04	197	62	4	1eb9ff8467118b943b5d443cb996168e1e1206b5
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 FCGR2A NCF2 NCOA4	1.63e-04	197	62	4	15bcfe6105c0b508811fb9bba0bc4312fea04f4c
ToppCell	COVID-19_Moderate-Classical_Monocyte\|World / disease group, cell group and cell class	TET2 PLBD1 FCGR2A NCF2	1.63e-04	197	62	4	16cf3939e700aef1e16159f0652ba2dfad287e7a
ToppCell	3'_v3-GI_small-bowel-Myeloid_Monocytic\|GI_small-bowel / Manually curated celltypes from each tissue	PLBD1 NLRP12 FCGR2A NCF2	1.63e-04	197	62	4	dcf0009057576a7db9065e644a3919d6de2ac8e6
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 FCGR2A NCF2 NCOA4	1.66e-04	198	62	4	110f7ebb3e1ec19508d4d2b973e1f64e7bdbb5b5
ToppCell	10x5'-lymph-node_spleen-Myeloid_Monocytic\|lymph-node_spleen / Manually curated celltypes from each tissue	PLBD1 NLRP12 FCGR2A NCF2	1.66e-04	198	62	4	2541f1095ed91e6789cb888cf39a208b8107726a
ToppCell	critical-Myeloid\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FCGR2A NCF2 DDX60L CLEC2B	1.66e-04	198	62	4	a5807517f8ca93b77f49f5787fd9036178b8fc2a
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 PLBD1 FCGR2A NCF2	1.66e-04	198	62	4	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	severe-Myeloid-Neutrophils_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FCGR2A NCF2 DDX60L CLEC2B	1.66e-04	198	62	4	636878836678a0715550fa09f2e3dac11c4d73fe
ToppCell	cellseq2-Immune-Immune_Myeloid-iMON-iMON\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PLBD1 NLRP12 FCGR2A NCF2	1.66e-04	198	62	4	a6aa113f0af4d25c032f440c3134fe4d88ca5055
ToppCell	10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes\|lymph-node_spleen / Manually curated celltypes from each tissue	PLBD1 NLRP12 FCGR2A NCF2	1.66e-04	198	62	4	934dacb67d71faa2f8732c39d7f8e64b0ee75396
ToppCell	mild-Myeloid\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PLBD1 FCGR2A NCF2 NCOA4	1.66e-04	198	62	4	908746384e10c6b833bb3bc124045d7b0bfd73b5
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	FCGR2A SBF2 NCF2 DDX60L	1.66e-04	198	62	4	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FCGR2A NCF2 DDX60L CHORDC1	1.66e-04	198	62	4	93cc01d91ffc543fd1a717ef47e02e532b50b665
ToppCell	severe-Myeloid\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PLBD1 FCGR2A NCF2 DDX60L	1.66e-04	198	62	4	d19902a6353445f9875dec59933b7553f5145b8b
ToppCell	NS-critical-LOC-Myeloid-Neutrophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FCGR2A NCF2 DDX60L CLEC2B	1.66e-04	198	62	4	e56417073e83061a43b9c41d6232d653904c1e90
ToppCell	cellseq2-Immune-Immune_Myeloid-iMON\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PLBD1 NLRP12 FCGR2A NCF2	1.66e-04	198	62	4	a0ceed8689d42be6b9cde89d6c182d10b3fb14fc
ToppCell	ILEUM-non-inflamed-(3)_DC2\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PLBD1 FCGR2A NCF2 NCOA4	1.66e-04	198	62	4	34157b3ff2c4867cacde38810999fac279051bc8
ToppCell	NS-critical-LOC-Myeloid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FCGR2A NCF2 DDX60L CLEC2B	1.66e-04	198	62	4	58f2bc88d92550fb0b7c2e46c63c49ec6777001c
ToppCell	NS-critical-d_16-33-Myeloid-Neutrophil\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FCGR2A NCF2 DDX60L CLEC2B	1.66e-04	198	62	4	fd5dd6d6d72356d4eac8637350405c69ccb7161c
ToppCell	Severe-B_intermediate-6\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PIKFYVE TET2 FCGR2A NCF2	1.66e-04	198	62	4	8402421dc060926e968efe39a4e907f1e8ae5b1f
Disease	X-13548 measurement	ZMYND11 DIP2C	3.17e-06	2	53	2	EFO_0021353
Disease	monocyte percentage of leukocytes	SELE PLBD1 NLRP12 DNAH12 THRB MAP3K14 PRKDC MUSK ZMYM4	5.60e-06	731	53	9	EFO_0007989
Disease	creatinine measurement	TET2 RAB19 MAP3K14 DIP2C SPATA20 CHORDC1 MUSK DDX1	3.75e-04	995	53	8	EFO_0004518
Disease	obsolete_red blood cell distribution width	THRB SULT2A1 LPCAT3 THG1L ZNF407 NCOA4 MUSK MAP3K1 KNL1	6.05e-04	1347	53	9	EFO_0005192
Disease	basophil percentage of leukocytes	FCGR2A CHD1 PRKDC CHORDC1	9.57e-04	243	53	4	EFO_0007992
Disease	prostate cancer (is_implicated_in)	THRB SULT2A1 CHD1	1.23e-03	117	53	3	DOID:10283 (is_implicated_in)
Disease	myeloid white cell count	SELE TET2 FCGR2A SBF2 MAP3K14 MYO1B MUSK	1.37e-03	937	53	7	EFO_0007988
Disease	waist-hip ratio	TET2 ZMYND11 SBF2 MAP3K14 ZNF407 PTGIS ZMYM4 KNL1	1.46e-03	1226	53	8	EFO_0004343

Protein segments in the cluster

Peptide	Gene	Start	Entry
DWKVMAFSKKGGHLE	EIF2AK3	316	Q9NZJ5
GETIMLRCHSWKDKP	FCGR2A	136	P12318
LKLLHAETKRMEGWC	DLGAP2	871	Q9P1A6
RKKHKDEDWQMSGSG	CHD1	141	O14646
MLIGNKCDLWEKRHV	RAB19	126	A4D1S5
MLHKWEMLKRAETAC	CDC42BPG	101	Q6DT37
KPFDLRSKMGKWCHH	POTEB2	16	H3BUK9
MWRLRCKAKDGTHVL	YOD1	46	Q5VVQ6
RIKSKEKCNDGKWHT	LAMA3	3056	Q16787
HSKIDKAMECVWKQK	NCF2	156	P19878
KVHEMLKKGWDAEGS	NUDCD3	326	Q8IVD9
KKGVCIWECIDRMHK	SBF2	1536	Q86WG5
KSLCMVKCHWKEKQD	LENG8	581	Q96PV6
WKMLKDKFNECGHVL	HNRNPM	666	P52272
MLGLIACFKAWKKHC	DDX60L	626	Q5H9U9
VKEWHGCRATKGLMK	DDX1	116	Q92499
HWRDIMKFCAKDPKV	DNAH12	941	Q6ZR08
DVGMWNDERCSKKKL	SELE	121	P16581
EEKGKAKWDACANMK	LPCAT3	306	Q6P1A2
KNLWEKMRHCSDKEL	KNL1	1976	Q8NG31
AIRKGFLACHLAMWK	PPM1D	141	O15297
SLKVFKRWDMGHCSA	PLBD1	216	Q6P4A8
KRWDMGHCSALIKVL	PLBD1	221	Q6P4A8
MGRKEEDDCSSWKKQ	CAMK1G	1	Q96NX5
KFVMCHLKGLSADRW	FADS2B	236	A8MWK0
KPFDLRSKMGKWCHH	POTEB3	16	A0JP26
LLHRWCSKKKDAAVM	KIR2DL4	261	Q99706
EKHKDSLNMWLCPRK	NCOA4	451	Q13772
KDLWKKICHHSSGME	PIKFYVE	356	Q9Y2I7
AKVACVKSRDMHWAL	DIP2C	586	Q9Y2E4
IWMHAEEREECKGKQ	KLC1	426	Q07866
VAHATEGKMARVCWK	MAP3K14	121	Q99558
REKLKATCMPAWKHE	MAP3K1	186	Q13233
KPFDLRSKMGKWCHH	POTED	16	Q86YR6
DKDHMCSVKSRLWKL	PTGIS	226	Q16647
KPFDLRSKMGKWCHH	POTEB	16	A0A0A6YYL3
KPFVLRSKMGKWCRH	POTEJ	16	P0CG39
HFLSCLDDKQWKMGK	SNX33	331	Q8WV41
KPFVLRSKMGKWCRH	POTEI	16	P0CG38
WAALKLHGKCDDVMR	SIRT7	306	Q9NRC8
AEILCLMHSKGDAKW	SULT2A1	51	Q06520
SWRKMATAEKQKHDG	PRKAA1	6	Q13131
KCSSDHWIGLKMAKN	CLEC2B	86	Q92478
LAQEGCTKGKHMWTK	CHORDC1	206	Q9UHD1
CTKGKHMWTKKDAGK	CHORDC1	211	Q9UHD1
HMWTKKDAGKKVVPC	CHORDC1	216	Q9UHD1
MWGACKVKVHDSLAT	THG1L	1	Q9NWX6
EWEKMKFSEKISCVH	SSX6P	36	Q7RTT6
NADKFKWDKMCHREA	ARHGAP28	441	Q9P2N2
GHKDWMDKCVCLLTA	SPATA20	661	Q8TB22
DWKLVGMSEACLHRK	THRB	26	P10828
WKLLKKDLCNTHLMR	PRKDC	1356	P78527
HVKRSMGWKKACDEL	ZMYND11	336	Q15326
MGWKKACDELELHQR	ZMYND11	341	Q15326
SFKGGWKCKDHTEML	ZNF140	116	P52738
EKPHKCKQCGMSFKW	ZNF57	501	Q68EA5
KECGKLFMWHTAFLK	ZNF594	711	Q96JF6
RKWTALHPGAKKMTE	ULBP1	156	Q9BZM6
HMKLHTGEKPFKCTW	ZNF407	1646	Q9C0G0
DCEKKEKNSWERMRH	TOGARAM1	1196	Q9Y4F4
KHGLALWEAKMAEKA	TET2	1911	Q6N021
KHDLAKRWGNHCKMC	ZMYM4	761	Q5VZL5
EKSLCWKVSPHIKMD	NLRP12	576	P59046
RGWKCRTHFLLMKKS	MYO1B	716	O43795
CAKEWLVMEEKTHRG	MUSK	406	O15146
KGKWMDLASKAGKHL	MYBPC1	96	Q00872